Back
LiveOne, Inc. Vs. AnaptysBio, Inc. Industry Stock Comparison
Sell
16
LVO
LiveOne, Inc.
Last Price:
$4.81
Seasonality Move:
1.45%
Sell
47
ANAB
AnaptysBio, Inc.
Last Price:
$57.92
Seasonality Move:
5.3%
Sell
16
LiveOne, Inc. (LVO)
is a Sell
Is LiveOne, Inc. a Buy, Sell or Hold?
-
The current LiveOne, Inc. [LVO] share price is $4.83. The Score for LVO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
LVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
AnaptysBio, Inc. (ANAB)
is a Sell
Is AnaptysBio, Inc. a Buy, Sell or Hold?
-
The current AnaptysBio, Inc. [ANAB] share price is $57.68. The Score for ANAB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ANAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LVO Stock Price Chart
What is LiveOne, Inc.'s stock price today?
-
The LiveOne, Inc. share price today is $4.83Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANAB Stock Price Chart
What is AnaptysBio, Inc.'s stock price today?
-
The AnaptysBio, Inc. share price today is $57.68The current trend is relatively stagnant and ANAB is experiencing slight selling pressure.
LVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 45.68 | Sell |
| Chaikin Money Flow: | 9134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.9 - 5.42) | Sell |
| Bollinger Bands (100): | (4.37 - 5.19) | Buy |
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 46.79 | Sell |
| Chaikin Money Flow: | -120538 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.32 - 64.78) | Sell |
| Bollinger Bands (100): | (41.49 - 58.03) | Buy |
LVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.88 | Sell |
| 20-day SMA: | 5.13 | Sell |
| 50-day SMA: | 5 | Sell |
| 200-day SMA: | 5.37 | Sell |
| 8-day EMA: | 4.92 | Sell |
| 20-day EMA: | 5.05 | Sell |
| 50-day EMA: | 5 | Sell |
| 200-day EMA: | 5.68 | Sell |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.51 | Sell |
| 20-day SMA: | 61.65 | Sell |
| 50-day SMA: | 55.97 | Buy |
| 200-day SMA: | 37.84 | Buy |
| 8-day EMA: | 58.76 | Sell |
| 20-day EMA: | 59.68 | Sell |
| 50-day EMA: | 56.33 | Buy |
| 200-day EMA: | 41.98 | Buy |
LiveOne, Inc. Earnings Growth & LVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.45 per share.
AnaptysBio, Inc. Earnings Growth & ANAB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, a decrease next quarter of $0.13 per share, a decrease this year of $2.63 per share, and an increase next year of $0.54 per share.
LiveOne, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AnaptysBio, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||